MicroRNA in myogenesis and muscle atrophy
Related Experiment Video
Updated: May 13, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
1Renal Division, Department of Medicine, Emory University, Atlanta, Georgia 30322, USA. xwang03@emory.edu
Purpose Of Review:
To understand the impact of microRNA on myogenesis and muscle wasting in order to provide valuable information for clinical investigation.
Recent Findings:
Muscle wasting increases the risk of morbidity/mortality in primary muscle diseases, secondary muscle disorders and elderly population. Muscle mass is controlled by several different signalling pathways. Insulin-like growth factor/PI3K/Akt is a positive signalling pathway, as it increases muscle mass by increasing protein synthesis and decreasing protein degradation. This pathway is directly and/or indirectly downregulated by miR-1, miR-133, miR-206 or miR-125b, and upregulated by miR-23a or miR-486. Myostatin and the transforming growth factor-β signalling pathway are negative regulators that cause muscle wasting. An increase of miR-27 reduces myostatin and increases muscle cell proliferation. Muscle regeneration capacity also plays a significant role in the regulation of muscle mass. This review comprehensively describes the effect of microRNA on myoblasts proliferation and differentiation, and summarizes the varied influences of microRNA on different muscle atrophy.
Summary:
Growing evidence indicates that microRNAs significantly impact muscle growth, regeneration and metabolism. MicroRNAs have a great potential to become diagnostic and/or prognostic markers, therapeutic agents and therapeutic targets.
Insights
MicroRNAs regulate muscle growth and wasting. These molecules influence myogenesis and muscle regeneration, offering potential as diagnostic markers and therapeutic targets for muscle disorders.
Area of Science:
- Molecular Biology
- Cell Biology
- Physiology
Background:
- Muscle wasting is a significant risk factor for morbidity and mortality in various conditions.
- Muscle mass is regulated by complex signaling pathways, including those involving insulin-like growth factor and myostatin.
- MicroRNAs (miRNAs) are emerging as key regulators in cellular processes.
Purpose of the Study:
- To elucidate the role of microRNAs in myogenesis and muscle wasting.
- To provide insights for future clinical investigations into muscle-related disorders.
Main Methods:
- This review synthesizes existing research on microRNA involvement in muscle biology.
- Analysis of signaling pathways affected by specific microRNAs.
Main Results:
- Specific microRNAs (e.g., miR-1, miR-133, miR-206, miR-125b) downregulate the IGF/PI3K/Akt pathway, impacting muscle mass.
- Other microRNAs (e.g., miR-23a, miR-486) upregulate this pathway.
- MicroRNAs like miR-27 influence myostatin signaling, affecting muscle cell proliferation and regeneration.
- MicroRNAs play varied roles in different types of muscle atrophy.
Conclusions:
- MicroRNAs profoundly influence muscle growth, regeneration, and metabolism.
- MicroRNAs hold significant potential as diagnostic/prognostic markers.
- MicroRNAs may serve as valuable therapeutic agents or targets for muscle diseases.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Satellite Stem Cells and Muscular Dystrophy
Cross-bridge Cycle

